We are live on ! Find out more
MITO

Stealth BioTherapeutics Corp. ADS
MITO

Delisted

MITO was delisted on the 15th of November, 2022.

Back to rankings

9 hedge funds and large institutions have $1.53M invested in Stealth BioTherapeutics Corp. ADS in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more capital invested

Capital invested by funds: $947K → $1.53M (+$585K)

10% less funds holding

Funds holding: 10 → 9 (-1)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$233K
2
UBS Group
UBS Group
Switzerland
+$26.6K
3
HF
HRT Financial
New York
+$25.1K

Top Sellers

Rank Fund Capital Flow
1
PM
Prosight Management
Texas
-$82K
2
Millennium Management
Millennium Management
New York
-$25.6K
3
Two Sigma Investments
Two Sigma Investments
New York
-$15K
4
Deutsche Bank
Deutsche Bank
Germany
-$12K
5
PC
PA Capital
Virginia
-$1.96K
Name Holding Trade Value Shares
Change 		Change in
Stake
PM
1
Prosight Management
Texas
$533K -$82K -45,023 -13%
Renaissance Technologies
2
Renaissance Technologies
New York
$468K +$233K +127,757 +100%
BBHC
3
Brown Brothers Harriman & Co
New York
$320K – – –
IC
4
Ikarian Capital
Texas
$69K – – –
Millennium Management
5
Millennium Management
New York
$40K -$25.6K -14,056 -39%
PC
6
PA Capital
Virginia
$39K -$1.96K -1,073 -5%
UBS Group
7
UBS Group
Switzerland
$27K +$26.6K +14,600 +3,650%
HF
8
HRT Financial
New York
$25K +$25.1K +13,751 New
Morgan Stanley
9
Morgan Stanley
New York
$11K – – –
Two Sigma Investments
10
Two Sigma Investments
New York
– -$15K -12,434 Closed
Deutsche Bank
11
Deutsche Bank
Germany
– -$12K -9,800 Closed

MITO Hedge Fund Activity: Q2 2020 in Review

9 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Stealth BioTherapeutics Corp. ADS (MITO) for Q2 2020, worth a combined $1.53M — up 62% from $947K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of MITO and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 2 added.

The largest buyer was Renaissance Technologies, adding an estimated $233K. The largest seller was Prosight Management, cutting an estimated $82K.

  • 9 institutional investors held Stealth BioTherapeutics Corp. ADS (MITO) as of Q2 2020, down from 10 in Q1 2020.
  • Funds reported $1.53M of Stealth BioTherapeutics Corp. ADS stock for Q2 2020, up 62% quarter-over-quarter.
  • 1 fund opened new Stealth BioTherapeutics Corp. ADS positions in Q2 2020 and 2 closed out, a net change of -1 holder.
  • The largest Stealth BioTherapeutics Corp. ADS buyer in Q2 2020 was Renaissance Technologies, an estimated $233K added.
  • The largest Stealth BioTherapeutics Corp. ADS seller in Q2 2020 was Prosight Management, an estimated $82K sold.

Based on aggregated 13F filings for Q2 2020.